Risk of incident mental disorders in hypertrophic cardiomyopathy: a nationwide propensity-matched study

Jun-Bean Park1,2, Je-Yeon Yun3,4, Bongsung Kim5

  • 1Department of Internal Medicine, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, 03080 Seoul, Republic of Korea.

Insights

Patients with hypertrophic cardiomyopathy (HCM) have a significantly higher risk of developing mental disorders, especially within the first year after diagnosis. Early screening for conditions like mood and anxiety disorders is crucial for these individuals.

Area of Science:

  • Cardiology
  • Psychiatry
  • Epidemiology

Background:

  • Hypertrophic cardiomyopathy (HCM) is a complex cardiac condition.
  • Mental health comorbidities are increasingly recognized in chronic diseases.

Purpose of the Study:

  • To investigate the association between hypertrophic cardiomyopathy (HCM) and the subsequent risk of mental disorders.
  • To quantify the risk and temporal patterns of mental disorder development in HCM patients.

Main Methods:

  • Retrospective propensity score-matched cohort study.
  • Utilized nationwide Korean National Health Insurance Service data.
  • Followed 4046 HCM patients and 12138 matched controls for incident mental disorders.

Main Results:

  • HCM patients exhibited a 1.72-fold increased risk of incident mental disorders (HR: 1.719).
  • The risk was substantially elevated within the first month post-diagnosis (HR: 3.074), decreasing over time but remaining significant.
  • Increased risk observed for mood, anxiety, stress-related, and somatoform disorders.

Conclusions:

  • Hypertrophic cardiomyopathy is a significant risk factor for developing mental disorders.
  • Prompt mental health screening is essential for HCM patients, particularly within the first year of diagnosis.
  • Early identification and management of mood and anxiety disorders can improve patient outcomes.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
37
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
41
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
65
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
27
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
19
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
38